SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABR Information Services (ABRX) -- Ignore unavailable to you. Want to Upgrade?

To: Russ Parker who wrote (111)3/13/1998 9:52:00 PM
From: Jim Mac  Read Replies (1) | Respond to of 156
 
Yeah, ASND wasn't a perfect comparison in all respects; and I do believe ABR can maintain 30% EPS growth rate over the next few years. However, beating the estimates doesn't mean much, besides maybe some analysts make poor estimates. Actually, the party's been over for a year. While ABRX probably won't go down to $10, $15-$20 is certainly a more reasonable valuation, all things considered. But I do like the copany very much.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News